cd44s Search Results


95
Miltenyi Biotec cd44 antibody
A-B. Cytometry analyses of Nestin, CK20, CD133, Oct3/4, <t>CD44</t> and CD44v9 on 10% FBS Colo205 growing cells (control) and serum-free growing cultures (week 1 to week 5).
Cd44 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44s/CD44+Antibody%2C+anti-human/pmc04162140-138-20-22
Average 95 stars, based on 1 article reviews
cd44 antibody - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Miltenyi Biotec cd44 viobright fitc
A-B. Cytometry analyses of Nestin, CK20, CD133, Oct3/4, <t>CD44</t> and CD44v9 on 10% FBS Colo205 growing cells (control) and serum-free growing cultures (week 1 to week 5).
Cd44 Viobright Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44s/CD44+Antibody%2C+anti-mouse%2C+REAfinity/pm39339987-114-33-37
Average 94 stars, based on 1 article reviews
cd44 viobright fitc - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Miltenyi Biotec rat monoclonal anti cd4 gk1 5 miltenyi biotec
A-B. Cytometry analyses of Nestin, CK20, CD133, Oct3/4, <t>CD44</t> and CD44v9 on 10% FBS Colo205 growing cells (control) and serum-free growing cultures (week 1 to week 5).
Rat Monoclonal Anti Cd4 Gk1 5 Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44s/CD44+Antibody%2C+anti-human%2C+REAlease/pmc09477743__41590_2022_1290_MOESM1_ESM-97-151-155
Average 93 stars, based on 1 article reviews
rat monoclonal anti cd4 gk1 5 miltenyi biotec - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems anti cd44
A-B. Cytometry analyses of Nestin, CK20, CD133, Oct3/4, <t>CD44</t> and CD44v9 on 10% FBS Colo205 growing cells (control) and serum-free growing cultures (week 1 to week 5).
Anti Cd44, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44s/Human+CD44s+Pan+Specific+Antibody/pmc12919374-125-8-9
Average 93 stars, based on 1 article reviews
anti cd44 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
Miltenyi Biotec anti human cd44
Figure 1. Flow cytometry and microsphere culture of BCSLCs. (A) CD24‑/low cells were isolated from MCF‑7 using immunomagnetic beads, and the expres- sion of CD24 in MCF‑7 and isolated CD24‑/low cells were assessed using flow cytometry. (a) Isotype control for (b); (b) MCF‑7 cells; (c) isotype control for (d); (d) isolated CD24‑/low cells. (B) <t>CD44+</t> cells were further isolated from CD24‑/low cells and the expression of <t>CD44</t> was assessed using flow cytometry. (a) Isotype control for (b); (b) CD44+ cells. (C) Expression of CD24 and CD44 in MCF‑7, BCSLCs and BCSLCs after eight passages. (a) isotype control for (b); (b) MCF‑7 cells; (c) CSLCs; (d) isotype control for (e); (e) BCSLCs after eight passages. (D) The isolated BCCSLCs were cultured in microspheres for 0 and 64 h in stem cell culture medium. BCSLC, breast cancer stem‑like cell; PE, phycoerythrin.
Anti Human Cd44, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44s/CD44+Antibody%2C+anti-human%2C+REAfinity/pm31746369-38-9-14
Average 95 stars, based on 1 article reviews
anti human cd44 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Miltenyi Biotec anti cd44
Figure 1. Flow cytometry and microsphere culture of BCSLCs. (A) CD24‑/low cells were isolated from MCF‑7 using immunomagnetic beads, and the expres- sion of CD24 in MCF‑7 and isolated CD24‑/low cells were assessed using flow cytometry. (a) Isotype control for (b); (b) MCF‑7 cells; (c) isotype control for (d); (d) isolated CD24‑/low cells. (B) <t>CD44+</t> cells were further isolated from CD24‑/low cells and the expression of <t>CD44</t> was assessed using flow cytometry. (a) Isotype control for (b); (b) CD44+ cells. (C) Expression of CD24 and CD44 in MCF‑7, BCSLCs and BCSLCs after eight passages. (a) isotype control for (b); (b) MCF‑7 cells; (c) CSLCs; (d) isotype control for (e); (e) BCSLCs after eight passages. (D) The isolated BCCSLCs were cultured in microspheres for 0 and 64 h in stem cell culture medium. BCSLC, breast cancer stem‑like cell; PE, phycoerythrin.
Anti Cd44, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44s/CD44+Antibody%2C+anti-mouse/pm38167862-233-41-43
Average 94 stars, based on 1 article reviews
anti cd44 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Miltenyi Biotec cd44 negative cd44 c666 1 cells
(A) Free-floating tumor spheres were formed from EBV-positive <t>C666-1</t> cells (left panel) and they demonstrated ability to differentiate comparably to monolayer cells upon administering complete medium (right panel). (B) By qRT-PCR, multiple stem cell-related genes (OCT4, NANOG, ALDH1, CKIT, <t>CD44,</t> CD133) were enriched in spheroids when compared to parental C666-1. Transcription of SOX2 was not increased in the spheroids. (C) SOX2 protein was frequently expressed in C666-1 sphere-forming cells. By flow cytometry, SOX2-positive (SOX2+) cells were found to be enriched in and constituted over 60% of sphere-forming cell population. (D) Over 80% of sphere-forming cells expressed cell surface marker <t>CD44</t> while CD44+ cells in detected in parental C666-1 and other NPC xenografts were significantly lower (all P <0.001). Histograms denoting mean ± SE (n≥3) with statistical significance calculated by t-test (* P <0.05, ** P <0.01, *** P <0.001).
Cd44 Negative Cd44 C666 1 Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44s/CD44H+Antibody%2C+anti-rat%2C+REAfinity/pmc03528656-244-3-22
Average 94 stars, based on 1 article reviews
cd44 negative cd44 c666 1 cells - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Addgene inc cd44s pwzl blast
(A) Free-floating tumor spheres were formed from EBV-positive <t>C666-1</t> cells (left panel) and they demonstrated ability to differentiate comparably to monolayer cells upon administering complete medium (right panel). (B) By qRT-PCR, multiple stem cell-related genes (OCT4, NANOG, ALDH1, CKIT, <t>CD44,</t> CD133) were enriched in spheroids when compared to parental C666-1. Transcription of SOX2 was not increased in the spheroids. (C) SOX2 protein was frequently expressed in C666-1 sphere-forming cells. By flow cytometry, SOX2-positive (SOX2+) cells were found to be enriched in and constituted over 60% of sphere-forming cell population. (D) Over 80% of sphere-forming cells expressed cell surface marker <t>CD44</t> while CD44+ cells in detected in parental C666-1 and other NPC xenografts were significantly lower (all P <0.001). Histograms denoting mean ± SE (n≥3) with statistical significance calculated by t-test (* P <0.05, ** P <0.01, *** P <0.001).
Cd44s Pwzl Blast, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44s/CD44S+pWZL-Blast+(Plasmid+%2319126)/pmc06586460-185-4-7
Average 90 stars, based on 1 article reviews
cd44s pwzl blast - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
R&D Systems cd44
FIGURE 3 | <t>CD44</t> is downregulated from the surface of oral neutrophils in HIV-infected individuals. (A) Representative flow cytometry plots of CD45 expression on blood and oral neutrophils. (B) Cumulative data of CD45 expression on oral neutrophils of HIV-infected versus healthy individuals. (C) Representative histogram plots, and (D) cumulative data of CD44 expression (MFI) in oral neutrophils of HV-infected individuals vs. HCs. (E) Representative flow cytometry plots of co-expression of CD44 and Gal-9 in oral and blood neutrophils in HIV-infected vs. healthy individuals. (F) Representative histogram plots, and (G) cumulative data of CD44 expression (MFI) in the blood and oral neutrophils of HIV-infected vs. healthy individuals. (H) Concentrations of soluble CD44 in the saliva of HIV-infected vs. healthy individuals as measured by ELISA. (I) Cumulative data showing blood neutrophil migration in the presence of soluble Gal-9 (1.5 ng/ml), anti-CD44 antibody (20 mg/ml), or soluble Gal-9 (1.5 ng/ml) plus anti- CD44 antibody while all wells were treated with fMLP (50 mm). (J) Cumulative results showing a positive correlation between the soluble CD44 with IL-6 in the saliva of HIV- infected individuals, calculated by Spearman correlation (K) Cumulative results showing a positive correlation between the soluble CD44 with IL-8 in the saliva of HIV- infected individuals, calculated by Spearman correlation. (L) Cumulative data showing a positive correlation between the soluble CD44 with bacterial Faith’s diversity, measured by Spearman correlation. (M) Cumulative data of percentages of neutrophils expression CD44 in the oral cavity of HCs versus HIV-infected individuals that were subjected to 16S gene sequencing. (N) Cumulative data of the intensity of CD44 expression on neutrophils from the oral cavity of HCs versus HIV-infected individuals that were subjected to 16S gene sequencing. ns, no significant.
Cd44, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44s/Human+CD44s+DuoSet+ELISA/pm34858437-80-1-2
Average 90 stars, based on 1 article reviews
cd44 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
Cyagen Biosciences cd44
FIGURE 3 | <t>CD44</t> is downregulated from the surface of oral neutrophils in HIV-infected individuals. (A) Representative flow cytometry plots of CD45 expression on blood and oral neutrophils. (B) Cumulative data of CD45 expression on oral neutrophils of HIV-infected versus healthy individuals. (C) Representative histogram plots, and (D) cumulative data of CD44 expression (MFI) in oral neutrophils of HV-infected individuals vs. HCs. (E) Representative flow cytometry plots of co-expression of CD44 and Gal-9 in oral and blood neutrophils in HIV-infected vs. healthy individuals. (F) Representative histogram plots, and (G) cumulative data of CD44 expression (MFI) in the blood and oral neutrophils of HIV-infected vs. healthy individuals. (H) Concentrations of soluble CD44 in the saliva of HIV-infected vs. healthy individuals as measured by ELISA. (I) Cumulative data showing blood neutrophil migration in the presence of soluble Gal-9 (1.5 ng/ml), anti-CD44 antibody (20 mg/ml), or soluble Gal-9 (1.5 ng/ml) plus anti- CD44 antibody while all wells were treated with fMLP (50 mm). (J) Cumulative results showing a positive correlation between the soluble CD44 with IL-6 in the saliva of HIV- infected individuals, calculated by Spearman correlation (K) Cumulative results showing a positive correlation between the soluble CD44 with IL-8 in the saliva of HIV- infected individuals, calculated by Spearman correlation. (L) Cumulative data showing a positive correlation between the soluble CD44 with bacterial Faith’s diversity, measured by Spearman correlation. (M) Cumulative data of percentages of neutrophils expression CD44 in the oral cavity of HCs versus HIV-infected individuals that were subjected to 16S gene sequencing. (N) Cumulative data of the intensity of CD44 expression on neutrophils from the oral cavity of HCs versus HIV-infected individuals that were subjected to 16S gene sequencing. ns, no significant.
Cd44, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44s/Cd44/pm31299915-48-6-29
Average 94 stars, based on 1 article reviews
cd44 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
R&D Systems human cd44s pan specific antibody
(a) Relative expression of CDH1 and VIM mRNA in MCF7_miR200c_KO and DOX-treated MDA-MB-231_i-miR200c (MB231_i-miR200c) cells normalized to wild type (unmodified MCF7 or untreated MB231_i-miR220c, respectively). (b) Western blot of MB231_i-miR200c cells with and without doxycycline-induction stained for EMT-relevant marker CDH1, VIM and <t>CD44s.</t> (c) Whiskers plot showing alterations in C N -values (from 40× images) in MB231_i-miR200c cells with and without doxycycline-induction for growth on TACS5- and TACS6-like structures. One-way ANOVA with Bonferroni multiple comparison test was performed to calculate P-values at a 95 % confidence interval (n (cells) > 50). (d) Corresponding confocal images of (c) at 10× magnification. Cells were stained for nuclei (blue) and the cytoskeleton (red). Comparison of trajectory analysis of (e) WT cells with MCF7_KO or (f) MB231_i-miR200c, respectively, performed with Fiji software (TrackMate). Displacement, mean migration speed, confinement ration and mean directional change were plotted as whiskers plot (5–95 percentiles). Statistical significance was assessed with a t -test based on > 150 cells/condition. Stars indicate statistical significance (∗∗∗P < 0.001; ∗∗P < 0.01; ∗P < 0.05, ns = not significant).
Human Cd44s Pan Specific Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44s/Human+CD44s+Pan+Specific+Antibody/pmc11699613-36-0-8
Average 93 stars, based on 1 article reviews
human cd44s pan specific antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
R&D Systems antibodies against cd44s
SALL4 knockdown reduces the expression of stemness and EMT-related genes and the activation of ERK, STAT3 and NF-κB pathways. ( a ) Quantitative RT-PCR analyses of Oct4, Sox2, Nanog, c-Myc and CD44 expression in control and SALL4 knockdown gastric cancer cells. ( b ) Western blot analyses of Oct4, Sox2, Nanog, c-Myc and CD44 expression in control and SALL4 knockdown gastric cancer cells. ( c ) Western blot analyses of p-ERK, ERK, p-p65, p65, p-STAT3 and STAT3 expression in control and SALL4 knockdown gastric cancer cells. ( d ) Quantitative RT-PCR analyses of <t>CD44s</t> and CD44v6 expression in control and SALL4 knockdown gastric cancer cells. ( e ) Western blot analyses of CD44s and CD44v6 expression in control and SALL4 knockdown gastric cancer cells. ( f ) CD44s and CD44v6 expression in tumour tissues and non-tumour tissues was detected in a tissue array by using immunohistochemistry. ( g ) The patients were divided into high or low group based on CD44s and CD44v6 expression. The overall survival probability was assessed by using the Kaplan–Meier curve. * P <0.05, ** P <0.01, compared to sh-Ctrl group.
Antibodies Against Cd44s, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44s/Human+CD44s+Pan+Specific+Antibody/pmc05141291-183-5-9
Average 94 stars, based on 1 article reviews
antibodies against cd44s - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


A-B. Cytometry analyses of Nestin, CK20, CD133, Oct3/4, CD44 and CD44v9 on 10% FBS Colo205 growing cells (control) and serum-free growing cultures (week 1 to week 5).

Journal: Genes & Cancer

Article Title: CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile

doi:

Figure Lengend Snippet: A-B. Cytometry analyses of Nestin, CK20, CD133, Oct3/4, CD44 and CD44v9 on 10% FBS Colo205 growing cells (control) and serum-free growing cultures (week 1 to week 5).

Article Snippet: The purity of sorted cells was evaluated by flow cytometry using FACSCalibur (BD Biosciences) after labeling with anti-human CD133/2 or CD44 antibody (Miltenyi Biotec).

Techniques: Cytometry, Control

A. Tumorsphere evaluation of CD133+ and CD133- sorted cells. B. Invasiveness of different cell fractions measured using a collagen-based invasion kit (relative DO measured at 560 nm). C. Survival assay after chemotherapy treatment with cisplatin and 5-FU. D. Metabolite quantification after CE-TOF-MS experiments. Only metabolites of interest for Colo205 cells cultured in 10% FBS (control; green bar), CD133+ sorted cells (red bar) and CD44+ sorted cells (yellow bar) are reported here.

Journal: Genes & Cancer

Article Title: CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile

doi:

Figure Lengend Snippet: A. Tumorsphere evaluation of CD133+ and CD133- sorted cells. B. Invasiveness of different cell fractions measured using a collagen-based invasion kit (relative DO measured at 560 nm). C. Survival assay after chemotherapy treatment with cisplatin and 5-FU. D. Metabolite quantification after CE-TOF-MS experiments. Only metabolites of interest for Colo205 cells cultured in 10% FBS (control; green bar), CD133+ sorted cells (red bar) and CD44+ sorted cells (yellow bar) are reported here.

Article Snippet: The purity of sorted cells was evaluated by flow cytometry using FACSCalibur (BD Biosciences) after labeling with anti-human CD133/2 or CD44 antibody (Miltenyi Biotec).

Techniques: Clonogenic Cell Survival Assay, Cell Culture, Control

Figure 1. Flow cytometry and microsphere culture of BCSLCs. (A) CD24‑/low cells were isolated from MCF‑7 using immunomagnetic beads, and the expres- sion of CD24 in MCF‑7 and isolated CD24‑/low cells were assessed using flow cytometry. (a) Isotype control for (b); (b) MCF‑7 cells; (c) isotype control for (d); (d) isolated CD24‑/low cells. (B) CD44+ cells were further isolated from CD24‑/low cells and the expression of CD44 was assessed using flow cytometry. (a) Isotype control for (b); (b) CD44+ cells. (C) Expression of CD24 and CD44 in MCF‑7, BCSLCs and BCSLCs after eight passages. (a) isotype control for (b); (b) MCF‑7 cells; (c) CSLCs; (d) isotype control for (e); (e) BCSLCs after eight passages. (D) The isolated BCCSLCs were cultured in microspheres for 0 and 64 h in stem cell culture medium. BCSLC, breast cancer stem‑like cell; PE, phycoerythrin.

Journal: International journal of molecular medicine

Article Title: Autophagy is essential for the endothelial differentiation of breast cancer stem‑like cells.

doi: 10.3892/ijmm.2019.4399

Figure Lengend Snippet: Figure 1. Flow cytometry and microsphere culture of BCSLCs. (A) CD24‑/low cells were isolated from MCF‑7 using immunomagnetic beads, and the expres- sion of CD24 in MCF‑7 and isolated CD24‑/low cells were assessed using flow cytometry. (a) Isotype control for (b); (b) MCF‑7 cells; (c) isotype control for (d); (d) isolated CD24‑/low cells. (B) CD44+ cells were further isolated from CD24‑/low cells and the expression of CD44 was assessed using flow cytometry. (a) Isotype control for (b); (b) CD44+ cells. (C) Expression of CD24 and CD44 in MCF‑7, BCSLCs and BCSLCs after eight passages. (a) isotype control for (b); (b) MCF‑7 cells; (c) CSLCs; (d) isotype control for (e); (e) BCSLCs after eight passages. (D) The isolated BCCSLCs were cultured in microspheres for 0 and 64 h in stem cell culture medium. BCSLC, breast cancer stem‑like cell; PE, phycoerythrin.

Article Snippet: The following primary antibodies were used: Fluorescein isothiocyanate (FITc)-conjugated anti-human cd44 (cat. no. 130-113-903; Miltenyi Biotec GmbH), phycoerythrin (PE)-conjugated anti-human cd24 (cat. no. 130-098-861; Miltenyi Biotec GmbH) PE-conjugated anti-human cd31 (cat. no. 130-110-807; Miltenyi Biotec GmbH) and FITc-conjugated anti-human cd105 (cat. no. 130-098-778; Miltenyi Biotec GmbH).

Techniques: Flow Cytometry, Isolation, Control, Expressing, Cell Culture, Stem Cell Culture

(A) Free-floating tumor spheres were formed from EBV-positive C666-1 cells (left panel) and they demonstrated ability to differentiate comparably to monolayer cells upon administering complete medium (right panel). (B) By qRT-PCR, multiple stem cell-related genes (OCT4, NANOG, ALDH1, CKIT, CD44, CD133) were enriched in spheroids when compared to parental C666-1. Transcription of SOX2 was not increased in the spheroids. (C) SOX2 protein was frequently expressed in C666-1 sphere-forming cells. By flow cytometry, SOX2-positive (SOX2+) cells were found to be enriched in and constituted over 60% of sphere-forming cell population. (D) Over 80% of sphere-forming cells expressed cell surface marker CD44 while CD44+ cells in detected in parental C666-1 and other NPC xenografts were significantly lower (all P <0.001). Histograms denoting mean ± SE (n≥3) with statistical significance calculated by t-test (* P <0.05, ** P <0.01, *** P <0.001).

Journal: PLoS ONE

Article Title: CD44+ Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma

doi: 10.1371/journal.pone.0052426

Figure Lengend Snippet: (A) Free-floating tumor spheres were formed from EBV-positive C666-1 cells (left panel) and they demonstrated ability to differentiate comparably to monolayer cells upon administering complete medium (right panel). (B) By qRT-PCR, multiple stem cell-related genes (OCT4, NANOG, ALDH1, CKIT, CD44, CD133) were enriched in spheroids when compared to parental C666-1. Transcription of SOX2 was not increased in the spheroids. (C) SOX2 protein was frequently expressed in C666-1 sphere-forming cells. By flow cytometry, SOX2-positive (SOX2+) cells were found to be enriched in and constituted over 60% of sphere-forming cell population. (D) Over 80% of sphere-forming cells expressed cell surface marker CD44 while CD44+ cells in detected in parental C666-1 and other NPC xenografts were significantly lower (all P <0.001). Histograms denoting mean ± SE (n≥3) with statistical significance calculated by t-test (* P <0.05, ** P <0.01, *** P <0.001).

Article Snippet: CD44-positive (CD44+) and CD44-negative (CD44−) C666-1 cells were separated by using anti-CD44 magnetic bead-coupled antibody and the magnetic-activated cell sorting (MACS) system (Miltenyi Biotec).

Techniques: Quantitative RT-PCR, Flow Cytometry, Marker

In vivo tumorigenic capacity of sphere-forming cells and unselected parental cells of  C666-1  in nude mice.

Journal: PLoS ONE

Article Title: CD44+ Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma

doi: 10.1371/journal.pone.0052426

Figure Lengend Snippet: In vivo tumorigenic capacity of sphere-forming cells and unselected parental cells of C666-1 in nude mice.

Article Snippet: CD44-positive (CD44+) and CD44-negative (CD44−) C666-1 cells were separated by using anti-CD44 magnetic bead-coupled antibody and the magnetic-activated cell sorting (MACS) system (Miltenyi Biotec).

Techniques: In Vivo

By flow cytometry, SOX2 was found to be preferentially expressed on CD44+ cells and coincidentally, SOX2 expression was rarely detected in CD44− cells. Cells coexpressing both CD44 and SOX2 were found to be enriched in spheroids. Histograms denoting mean ± SE (n≥3) with statistical significance calculated by t-test (* P <0.05, ** P <0.01, *** P <0.001).

Journal: PLoS ONE

Article Title: CD44+ Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma

doi: 10.1371/journal.pone.0052426

Figure Lengend Snippet: By flow cytometry, SOX2 was found to be preferentially expressed on CD44+ cells and coincidentally, SOX2 expression was rarely detected in CD44− cells. Cells coexpressing both CD44 and SOX2 were found to be enriched in spheroids. Histograms denoting mean ± SE (n≥3) with statistical significance calculated by t-test (* P <0.05, ** P <0.01, *** P <0.001).

Article Snippet: CD44-positive (CD44+) and CD44-negative (CD44−) C666-1 cells were separated by using anti-CD44 magnetic bead-coupled antibody and the magnetic-activated cell sorting (MACS) system (Miltenyi Biotec).

Techniques: Flow Cytometry, Expressing

CD44+ cell fraction exhibited a significantly higher (A) clone formation efficiency and (B) sphere-forming efficiency when compared to CD44− cell fraction. In addition, (C) CD44+ cells exhibited significantly higher proliferation rate than CD44− cells. (D) Developmental hierarchy feature of CD44+ cells. Percentage of CD44+ cells were continually reduced in the isolated CD44+ cell fraction over time. (E) CD44+ cells exhibited higher resistance to 5-FU treatment when compared to the CD44− and parental C666-1 cells. All graphs denoting mean ± SE (n≥3) with statistical significance calculated by t-test (* P <0.05, ** P <0.01, *** P <0.001).

Journal: PLoS ONE

Article Title: CD44+ Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma

doi: 10.1371/journal.pone.0052426

Figure Lengend Snippet: CD44+ cell fraction exhibited a significantly higher (A) clone formation efficiency and (B) sphere-forming efficiency when compared to CD44− cell fraction. In addition, (C) CD44+ cells exhibited significantly higher proliferation rate than CD44− cells. (D) Developmental hierarchy feature of CD44+ cells. Percentage of CD44+ cells were continually reduced in the isolated CD44+ cell fraction over time. (E) CD44+ cells exhibited higher resistance to 5-FU treatment when compared to the CD44− and parental C666-1 cells. All graphs denoting mean ± SE (n≥3) with statistical significance calculated by t-test (* P <0.05, ** P <0.01, *** P <0.001).

Article Snippet: CD44-positive (CD44+) and CD44-negative (CD44−) C666-1 cells were separated by using anti-CD44 magnetic bead-coupled antibody and the magnetic-activated cell sorting (MACS) system (Miltenyi Biotec).

Techniques: Isolation

(A) By qRT-PCR, multiple EBV genes (EBER, BARF1, LMP1, LMP2A, EBNA1 and BZLF1) were found to be overexpressed in spheroids when compared to monolayer C666-1 cells. EBV copy number in these cells was determined by qPCR. (B) Selected genes aberrantly expressed in spheroids were confirmed by qRT-PCR. The significantly upregulated genes include chemokines and receptors (CCR7, CCL4, CX3CL1 and IL-8), cell adhesion molecule SELE, signaling molecules (GLI1, FOXN4) and ABC transporters (ABCC3, ABCC11). (C) Cell surface-expressed CCR7 was found to be frequently expressed in sphere-forming cells (>60%) by flow cytometry. The CCR7+ cell subpopulation was also detected in NPC lines and primary tumors (<5%). (D) CD44+CCR7+cells were also found to be enriched in spheroids. Histograms denoting mean ± SE (n≥3) with statistical significance calculated by t-test (* P <0.05, ** P <0.01, *** P <0.001).

Journal: PLoS ONE

Article Title: CD44+ Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma

doi: 10.1371/journal.pone.0052426

Figure Lengend Snippet: (A) By qRT-PCR, multiple EBV genes (EBER, BARF1, LMP1, LMP2A, EBNA1 and BZLF1) were found to be overexpressed in spheroids when compared to monolayer C666-1 cells. EBV copy number in these cells was determined by qPCR. (B) Selected genes aberrantly expressed in spheroids were confirmed by qRT-PCR. The significantly upregulated genes include chemokines and receptors (CCR7, CCL4, CX3CL1 and IL-8), cell adhesion molecule SELE, signaling molecules (GLI1, FOXN4) and ABC transporters (ABCC3, ABCC11). (C) Cell surface-expressed CCR7 was found to be frequently expressed in sphere-forming cells (>60%) by flow cytometry. The CCR7+ cell subpopulation was also detected in NPC lines and primary tumors (<5%). (D) CD44+CCR7+cells were also found to be enriched in spheroids. Histograms denoting mean ± SE (n≥3) with statistical significance calculated by t-test (* P <0.05, ** P <0.01, *** P <0.001).

Article Snippet: CD44-positive (CD44+) and CD44-negative (CD44−) C666-1 cells were separated by using anti-CD44 magnetic bead-coupled antibody and the magnetic-activated cell sorting (MACS) system (Miltenyi Biotec).

Techniques: Quantitative RT-PCR, Flow Cytometry

Selection of aberrantly expressed genes in sphere-forming cells compared to monolayer  C666-1  cells.

Journal: PLoS ONE

Article Title: CD44+ Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma

doi: 10.1371/journal.pone.0052426

Figure Lengend Snippet: Selection of aberrantly expressed genes in sphere-forming cells compared to monolayer C666-1 cells.

Article Snippet: CD44-positive (CD44+) and CD44-negative (CD44−) C666-1 cells were separated by using anti-CD44 magnetic bead-coupled antibody and the magnetic-activated cell sorting (MACS) system (Miltenyi Biotec).

Techniques: Selection, Significance Assay, Variant Assay, Binding Assay, Histone Deacetylase Assay, RNA Binding Assay

Representative primary NPC cases with high (A), medium (B), low (C) expression of CCR7. (D) Primary NPC with absence of CCR7 expression was shown. CCR7 staining were detected in few infiltrating lymphocytes, but not in the tumor cells. Primary tumors with high (E) and medium (F) CD44 expression were shown. In (G) and (H), weak CD44 expression was detected in the tumor cells while strong CD44 staining in infiltrating lymphocytes was commonly found.

Journal: PLoS ONE

Article Title: CD44+ Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma

doi: 10.1371/journal.pone.0052426

Figure Lengend Snippet: Representative primary NPC cases with high (A), medium (B), low (C) expression of CCR7. (D) Primary NPC with absence of CCR7 expression was shown. CCR7 staining were detected in few infiltrating lymphocytes, but not in the tumor cells. Primary tumors with high (E) and medium (F) CD44 expression were shown. In (G) and (H), weak CD44 expression was detected in the tumor cells while strong CD44 staining in infiltrating lymphocytes was commonly found.

Article Snippet: CD44-positive (CD44+) and CD44-negative (CD44−) C666-1 cells were separated by using anti-CD44 magnetic bead-coupled antibody and the magnetic-activated cell sorting (MACS) system (Miltenyi Biotec).

Techniques: Expressing, Staining

To evaluate the function of CCR7 in CSCs, C666-1 was treated with CCR7 blocking antibody and its proliferation, clone-forming and sphere-forming efficiency were investigated. (A) Proliferation of CD44+ cells was inhibited after treatment with CCR7 blocking antibody. (B) The clone formation efficiency of C666-1 cells was diminished after CCR7 blocking and (C) the spheroid-forming ability was significantly inihibited ( P <0.001) when compared to untreated controls. Histograms denoting mean ± SE (n≥3) with statistical significance calculated by t-test (* P <0.05, *** P <0.001).

Journal: PLoS ONE

Article Title: CD44+ Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma

doi: 10.1371/journal.pone.0052426

Figure Lengend Snippet: To evaluate the function of CCR7 in CSCs, C666-1 was treated with CCR7 blocking antibody and its proliferation, clone-forming and sphere-forming efficiency were investigated. (A) Proliferation of CD44+ cells was inhibited after treatment with CCR7 blocking antibody. (B) The clone formation efficiency of C666-1 cells was diminished after CCR7 blocking and (C) the spheroid-forming ability was significantly inihibited ( P <0.001) when compared to untreated controls. Histograms denoting mean ± SE (n≥3) with statistical significance calculated by t-test (* P <0.05, *** P <0.001).

Article Snippet: CD44-positive (CD44+) and CD44-negative (CD44−) C666-1 cells were separated by using anti-CD44 magnetic bead-coupled antibody and the magnetic-activated cell sorting (MACS) system (Miltenyi Biotec).

Techniques: Blocking Assay

FIGURE 3 | CD44 is downregulated from the surface of oral neutrophils in HIV-infected individuals. (A) Representative flow cytometry plots of CD45 expression on blood and oral neutrophils. (B) Cumulative data of CD45 expression on oral neutrophils of HIV-infected versus healthy individuals. (C) Representative histogram plots, and (D) cumulative data of CD44 expression (MFI) in oral neutrophils of HV-infected individuals vs. HCs. (E) Representative flow cytometry plots of co-expression of CD44 and Gal-9 in oral and blood neutrophils in HIV-infected vs. healthy individuals. (F) Representative histogram plots, and (G) cumulative data of CD44 expression (MFI) in the blood and oral neutrophils of HIV-infected vs. healthy individuals. (H) Concentrations of soluble CD44 in the saliva of HIV-infected vs. healthy individuals as measured by ELISA. (I) Cumulative data showing blood neutrophil migration in the presence of soluble Gal-9 (1.5 ng/ml), anti-CD44 antibody (20 mg/ml), or soluble Gal-9 (1.5 ng/ml) plus anti- CD44 antibody while all wells were treated with fMLP (50 mm). (J) Cumulative results showing a positive correlation between the soluble CD44 with IL-6 in the saliva of HIV- infected individuals, calculated by Spearman correlation (K) Cumulative results showing a positive correlation between the soluble CD44 with IL-8 in the saliva of HIV- infected individuals, calculated by Spearman correlation. (L) Cumulative data showing a positive correlation between the soluble CD44 with bacterial Faith’s diversity, measured by Spearman correlation. (M) Cumulative data of percentages of neutrophils expression CD44 in the oral cavity of HCs versus HIV-infected individuals that were subjected to 16S gene sequencing. (N) Cumulative data of the intensity of CD44 expression on neutrophils from the oral cavity of HCs versus HIV-infected individuals that were subjected to 16S gene sequencing. ns, no significant.

Journal: Frontiers in immunology

Article Title: Differential Signature of the Microbiome and Neutrophils in the Oral Cavity of HIV-Infected Individuals.

doi: 10.3389/fimmu.2021.780910

Figure Lengend Snippet: FIGURE 3 | CD44 is downregulated from the surface of oral neutrophils in HIV-infected individuals. (A) Representative flow cytometry plots of CD45 expression on blood and oral neutrophils. (B) Cumulative data of CD45 expression on oral neutrophils of HIV-infected versus healthy individuals. (C) Representative histogram plots, and (D) cumulative data of CD44 expression (MFI) in oral neutrophils of HV-infected individuals vs. HCs. (E) Representative flow cytometry plots of co-expression of CD44 and Gal-9 in oral and blood neutrophils in HIV-infected vs. healthy individuals. (F) Representative histogram plots, and (G) cumulative data of CD44 expression (MFI) in the blood and oral neutrophils of HIV-infected vs. healthy individuals. (H) Concentrations of soluble CD44 in the saliva of HIV-infected vs. healthy individuals as measured by ELISA. (I) Cumulative data showing blood neutrophil migration in the presence of soluble Gal-9 (1.5 ng/ml), anti-CD44 antibody (20 mg/ml), or soluble Gal-9 (1.5 ng/ml) plus anti- CD44 antibody while all wells were treated with fMLP (50 mm). (J) Cumulative results showing a positive correlation between the soluble CD44 with IL-6 in the saliva of HIV- infected individuals, calculated by Spearman correlation (K) Cumulative results showing a positive correlation between the soluble CD44 with IL-8 in the saliva of HIV- infected individuals, calculated by Spearman correlation. (L) Cumulative data showing a positive correlation between the soluble CD44 with bacterial Faith’s diversity, measured by Spearman correlation. (M) Cumulative data of percentages of neutrophils expression CD44 in the oral cavity of HCs versus HIV-infected individuals that were subjected to 16S gene sequencing. (N) Cumulative data of the intensity of CD44 expression on neutrophils from the oral cavity of HCs versus HIV-infected individuals that were subjected to 16S gene sequencing. ns, no significant.

Article Snippet: Similarly, CD44 (R&D Systems; DY7045-05) and Gal-9 (R&D; DY 2045) concentrations were quantified by ELISA.

Techniques: Infection, Cytometry, Expressing, Enzyme-linked Immunosorbent Assay, Migration, Sequencing

FIGURE 4 | Differential expression of CD32 on neutrophils from HIV-infected individuals versus healthy individuals. (A) Representative flow cytometry plots of CD32 expression on neutrophils of an HIV-infected vs. a healthy individual. (B) Representative histogram plots, and (C) cumulative data of CD32 expression (MFI) in oral neutrophils from HIV-infected vs. healthy individuals. (D) Cumulative data of CD32 expression in regards to CD44 on neutrophils of HCs vs. HIV-infected individuals. flow cytometry plot of neutrophils from oral washes and their coexpression of CD44 and CD32 in HIV patients shown in red and HCs in black. Note the higher expression of CD32 in neutrophils of HIV patients. (E) Representative histogram plots, and (F) cumulative data of CD32 expression (MFI) in CD44-, and (G) CD44+

Journal: Frontiers in immunology

Article Title: Differential Signature of the Microbiome and Neutrophils in the Oral Cavity of HIV-Infected Individuals.

doi: 10.3389/fimmu.2021.780910

Figure Lengend Snippet: FIGURE 4 | Differential expression of CD32 on neutrophils from HIV-infected individuals versus healthy individuals. (A) Representative flow cytometry plots of CD32 expression on neutrophils of an HIV-infected vs. a healthy individual. (B) Representative histogram plots, and (C) cumulative data of CD32 expression (MFI) in oral neutrophils from HIV-infected vs. healthy individuals. (D) Cumulative data of CD32 expression in regards to CD44 on neutrophils of HCs vs. HIV-infected individuals. flow cytometry plot of neutrophils from oral washes and their coexpression of CD44 and CD32 in HIV patients shown in red and HCs in black. Note the higher expression of CD32 in neutrophils of HIV patients. (E) Representative histogram plots, and (F) cumulative data of CD32 expression (MFI) in CD44-, and (G) CD44+

Article Snippet: Similarly, CD44 (R&D Systems; DY7045-05) and Gal-9 (R&D; DY 2045) concentrations were quantified by ELISA.

Techniques: Quantitative Proteomics, Infection, Cytometry, Expressing

(a) Relative expression of CDH1 and VIM mRNA in MCF7_miR200c_KO and DOX-treated MDA-MB-231_i-miR200c (MB231_i-miR200c) cells normalized to wild type (unmodified MCF7 or untreated MB231_i-miR220c, respectively). (b) Western blot of MB231_i-miR200c cells with and without doxycycline-induction stained for EMT-relevant marker CDH1, VIM and CD44s. (c) Whiskers plot showing alterations in C N -values (from 40× images) in MB231_i-miR200c cells with and without doxycycline-induction for growth on TACS5- and TACS6-like structures. One-way ANOVA with Bonferroni multiple comparison test was performed to calculate P-values at a 95 % confidence interval (n (cells) > 50). (d) Corresponding confocal images of (c) at 10× magnification. Cells were stained for nuclei (blue) and the cytoskeleton (red). Comparison of trajectory analysis of (e) WT cells with MCF7_KO or (f) MB231_i-miR200c, respectively, performed with Fiji software (TrackMate). Displacement, mean migration speed, confinement ration and mean directional change were plotted as whiskers plot (5–95 percentiles). Statistical significance was assessed with a t -test based on > 150 cells/condition. Stars indicate statistical significance (∗∗∗P < 0.001; ∗∗P < 0.01; ∗P < 0.05, ns = not significant).

Journal: Materials Today Bio

Article Title: Cellular EMT-status governs contact guidance in an electrospun TACS-mimicking in vitro model

doi: 10.1016/j.mtbio.2024.101401

Figure Lengend Snippet: (a) Relative expression of CDH1 and VIM mRNA in MCF7_miR200c_KO and DOX-treated MDA-MB-231_i-miR200c (MB231_i-miR200c) cells normalized to wild type (unmodified MCF7 or untreated MB231_i-miR220c, respectively). (b) Western blot of MB231_i-miR200c cells with and without doxycycline-induction stained for EMT-relevant marker CDH1, VIM and CD44s. (c) Whiskers plot showing alterations in C N -values (from 40× images) in MB231_i-miR200c cells with and without doxycycline-induction for growth on TACS5- and TACS6-like structures. One-way ANOVA with Bonferroni multiple comparison test was performed to calculate P-values at a 95 % confidence interval (n (cells) > 50). (d) Corresponding confocal images of (c) at 10× magnification. Cells were stained for nuclei (blue) and the cytoskeleton (red). Comparison of trajectory analysis of (e) WT cells with MCF7_KO or (f) MB231_i-miR200c, respectively, performed with Fiji software (TrackMate). Displacement, mean migration speed, confinement ration and mean directional change were plotted as whiskers plot (5–95 percentiles). Statistical significance was assessed with a t -test based on > 150 cells/condition. Stars indicate statistical significance (∗∗∗P < 0.001; ∗∗P < 0.01; ∗P < 0.05, ns = not significant).

Article Snippet: Human CD44s Pan Specific Antibody was purchased from R&D Systems (Minneapolis, MN, USA).

Techniques: Expressing, Western Blot, Staining, Marker, Comparison, Software, Migration

SALL4 knockdown reduces the expression of stemness and EMT-related genes and the activation of ERK, STAT3 and NF-κB pathways. ( a ) Quantitative RT-PCR analyses of Oct4, Sox2, Nanog, c-Myc and CD44 expression in control and SALL4 knockdown gastric cancer cells. ( b ) Western blot analyses of Oct4, Sox2, Nanog, c-Myc and CD44 expression in control and SALL4 knockdown gastric cancer cells. ( c ) Western blot analyses of p-ERK, ERK, p-p65, p65, p-STAT3 and STAT3 expression in control and SALL4 knockdown gastric cancer cells. ( d ) Quantitative RT-PCR analyses of CD44s and CD44v6 expression in control and SALL4 knockdown gastric cancer cells. ( e ) Western blot analyses of CD44s and CD44v6 expression in control and SALL4 knockdown gastric cancer cells. ( f ) CD44s and CD44v6 expression in tumour tissues and non-tumour tissues was detected in a tissue array by using immunohistochemistry. ( g ) The patients were divided into high or low group based on CD44s and CD44v6 expression. The overall survival probability was assessed by using the Kaplan–Meier curve. * P <0.05, ** P <0.01, compared to sh-Ctrl group.

Journal: Oncogenesis

Article Title: SALL4 promotes gastric cancer progression through activating CD44 expression

doi: 10.1038/oncsis.2016.69

Figure Lengend Snippet: SALL4 knockdown reduces the expression of stemness and EMT-related genes and the activation of ERK, STAT3 and NF-κB pathways. ( a ) Quantitative RT-PCR analyses of Oct4, Sox2, Nanog, c-Myc and CD44 expression in control and SALL4 knockdown gastric cancer cells. ( b ) Western blot analyses of Oct4, Sox2, Nanog, c-Myc and CD44 expression in control and SALL4 knockdown gastric cancer cells. ( c ) Western blot analyses of p-ERK, ERK, p-p65, p65, p-STAT3 and STAT3 expression in control and SALL4 knockdown gastric cancer cells. ( d ) Quantitative RT-PCR analyses of CD44s and CD44v6 expression in control and SALL4 knockdown gastric cancer cells. ( e ) Western blot analyses of CD44s and CD44v6 expression in control and SALL4 knockdown gastric cancer cells. ( f ) CD44s and CD44v6 expression in tumour tissues and non-tumour tissues was detected in a tissue array by using immunohistochemistry. ( g ) The patients were divided into high or low group based on CD44s and CD44v6 expression. The overall survival probability was assessed by using the Kaplan–Meier curve. * P <0.05, ** P <0.01, compared to sh-Ctrl group.

Article Snippet: Tissue array was incubated with antibodies against CD44s (MAB7045; R&D Systems, Minneapolis, MN, USA) and CD44v6 (AB2080; Millipore, Billerica, MS, USA).

Techniques: Knockdown, Expressing, Activation Assay, Quantitative RT-PCR, Control, Western Blot, Immunohistochemistry